Topic: Price Transparency
The debate over the state of the 340B drug discount program continues to swirl.
CVS and Aetna shareholders voted Tuesday to approve the recently announced deal valued at $69 billion.
Most doctors who wrote prescriptions to Medicare patients in 2014 and 2015 for opioids received a payment from pharma companies.
HHS Secretary Alex Azar said the agency wants to work with payers to accelerate the industry's transition to value-based care.
HHS Secretary Alex Azar outlined four priorities for the agency this week, including accelerating value-based payments.
Twelve of the 500 doctors paid by a pharmaceutical company to promote its drug were disciplined by state medical boards.
President Donald Trump’s top choice to replace Tom Price as Health and Human Services secretary, Alex Azar, is a departure from the norm.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts for prescription drugs.
Telemedicine services and delivery formats are evolving at large hospitals and health systems, healthcare leaders tell FierceHealthcare.
The Maryland Health Care Commission has launched a new online pricing tool that allows state residents to compare the costs of common procedures.